GAD1 and type 1 diabetes mellitus: Therefore, it has been reported that Tregs suppress GAD-reactive T-cells in patients with type 1 diabetes mellitus more than 5 years after onset, and it is possible that some immune abnormalities may still be present in PBMCs over time.